Cargando…
Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis
BACKGROUND: Paclitaxel (PTX) is one of the widely used chemotherapy drugs in breast cancer (BC) treatment. Unfortunately, the survival rate of metastatic BC patients remains poor due to PTX resistance. Therefore, uncovering the underlying mechanism behind the PTX resistance of BC cells is crucial fo...
Autores principales: | Yang, Weiping, Gong, Piguo, Yang, Yifeng, Yang, Chunyan, Yang, Baohui, Ren, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108723/ https://www.ncbi.nlm.nih.gov/pubmed/32273769 http://dx.doi.org/10.2147/CMAR.S238513 |
Ejemplares similares
-
Decrease of Let-7f in Low-Dose Metronomic Paclitaxel Chemotherapy Contributed to Upregulation of Thrombospondin-1 in Breast Cancer
por: Tao, Wei-Yang, et al.
Publicado: (2015) -
An anti-let-7 sponge decoys and decays endogenous let-7 functions
por: Yang, Xiangling, et al.
Publicado: (2012) -
circRNA Profiling Reveals an Abundant circFUT10 that Promotes Adipocyte Proliferation and Inhibits Adipocyte Differentiation via Sponging let-7
por: Jiang, Rui, et al.
Publicado: (2020) -
Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast
por: Gong, Piguo, et al.
Publicado: (2021) -
circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury
por: Zhu, Jiang, et al.
Publicado: (2022)